Vitamin D deficiency among patients with pulmonary hypertension. 2019

Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
División Cardiología y Servicio de Neumonología, Hospital General de Agudos "Juan A. Fernández", Ciudad Autónoma de Buenos Aires, Argentina. aatamanu@cas.austral.edu.ar.

BACKGROUND There is little information about vitamin D (Vit D) deficiency in patients with pulmonary hypertension (PH). The objective of this study was: 1) compare Vit D levels between patients with PH, left ventricular failure (LVF) and healthy subjects (HS); 2) correlate, in patients with PH, Vit D levels with prognosis-related variables, such as the 6-min walk test (6MWT). METHODS Vitamin D levels were measured in a cross-sectional study in 126 patients from one of three groups: patients with PH (n = 53), patients with LVF (n = 42) and healthy subjects (n = 31). In all groups, 8-h fasting blood samples were obtained in the morning. In the PH and the LVF group, functional class (WHO criteria), metres covered in the 6MWT and echocardiographic parameters were analysed. In the PH group, plasma N terminal pro B type natriuretic peptide (NT-proBNP) level was analysed and a complete haemodynamic evaluation by right heart catheterisation was made. RESULTS Mean Vit D levels were lower in PH than in both other groups (ng/ml, mean ± SD): PH 19.25 ± 10, LVF 25.68 ± 12, HS 28.8 ± 12 (PH vs LVF p = 0.017, PH vs HS p = 0.001 and HS vs LVF p = 0.46). Vit D deficiency prevalence was higher in PH as compared to the other groups (PH 53.8%, LVF 45.2%, HS 25%, p = 0.01). Patients with PH in functional class (FC; WHO criteria) III-IV had higher Vit D deficiency prevalence than those in FC I-II (86.7% vs 40.5%, p = 0.003). There was a significant linear correlation between the 6MWT and Vit D levels in PH (p < 0.01), but not in LVF (p = 0.69). CONCLUSIONS Vit D levels were lower in patients with PH as compared to patients with LVF and HS and correlated directly with 6-min walk distance.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
January 2016, Caspian journal of internal medicine,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
May 2021, Cureus,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
January 2013, Prague medical report,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
October 2009, BJU international,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
September 2013, Journal of translational medicine,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
May 2021, Clinical nutrition (Edinburgh, Scotland),
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
January 2016, Journal of clinical orthopaedics and trauma,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
November 2015, Journal of the American Society of Hypertension : JASH,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
November 2000, Ugeskrift for laeger,
Andrés N Atamañuk, and Diego F Litewka, and Sergio J Baratta, and Ignacio M Seropian, and Graciela Perez Prados, and Miguel O Payaslian, and Juan P Ortiz Fragola, and Pilar Escribano Subias
January 1998, Ugeskrift for laeger,
Copied contents to your clipboard!